PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2010.42.4.2032010424203Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib EraNae Yu Kim, Jong Mu Sun, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jin-Wook Kim, Sook-Hyang Jeong, Jong Seok Leehttp://www.e-crt.org/upload/pdf/crt-42-203.pdf, http://www.e-crt.org/upload/pdf/crt-42-203.pdf
Digestive Diseases10.1159/0004802572017356611-617Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute ExperienceKazuomi Ueshima, Naoshi Nishida, Masatoshi Kudohttps://www.karger.com/Article/Pdf/480257, https://www.karger.com/Article/Pdf/480257
Chemotherapy10.1159/0003717362014602112-118Combination of Matrine and Sorafenib Decreases the Aggressive Phenotypes of Hepatocellular Carcinoma CellsYan Lin, Lianjie Lin, Yu Jin, Ying Zhang, Dongxu Wang, Yue Tan, Changqing Zhenghttps://www.karger.com/Article/Pdf/371736, https://www.karger.com/Article/Pdf/371736
Hepatology10.1002/hep.2343920095162232-2233Hepatocellular carcinoma: Sorafenib before liver transplantation?Alain Braillonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.23439, http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23439/fullpdf
Journal of Hepatology10.1016/s0168-8278(20)32242-x202073S907-S908Hepatic arterial infusion chemotherapy combined with sorafenib versus sorafenib monotherapy in advanced hepatocellular carcinoma: a systemic review and meta-analysisZhiyuan Yao, Anxin Chen, Mingyu Chenhttps://api.elsevier.com/content/article/PII:S016882782032242X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S016882782032242X?httpAccept=text/plain
Journal of Hepatology10.1016/s0168-8278(16)00173-22016642S209-S210Prospective Randomized Controlled Phase III Trial Comparing the Efficacy of Sorafenib versus Sorafenib in Combination with Low-Dose Cisplatin/Fluorouracil Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular CarcinomaM. Kudo, K. Ueshima, O. Yokosuka, S. Obi, N. Izumi, H. Aikata, H. Nagano, E. Hatano, Y. Sasaki, K. Hino, T. Kumada, K. Yamamoto, Y. Imai, S. Iwadou, C. Ogawa, T. Okusaka, Y. Arai, F. Kanai, K. Akazawahttps://api.elsevier.com/content/article/PII:S0168827816001732?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0168827816001732?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(91)90444-b199176397Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lunghttps://api.elsevier.com/content/article/PII:016950029190444B?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029190444B?httpAccept=text/plain
The Lancet Oncology10.1016/s1470-2045(16)30447-820161710e424Sorafenib plus cisplatin for hepatocellular carcinomaVicki Browerhttps://api.elsevier.com/content/article/PII:S1470204516304478?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1470204516304478?httpAccept=text/plain
Current Oncology10.3747/co.v18i5.8002011186297-303Patterns of Presentation, Referral, and Treatment of Hepatocellular Carcinoma in a Pre-Sorafenib Era: Experience of a Canadian Provincial Cancer AgencyT. Sundaralingam, S. Gillhttps://www.mdpi.com/1718-7729/18/6/800/pdf
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.121912014103255-260Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II studyVichien Srimuninnimit, Virote Sriuranpong, Suthida Suwanvechohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12191, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12191/fullpdf